SmarTrend identified an Uptrend for Pfenex Inc (AMEX:PFNX) on December 2nd, 2019 at $10.27. In approximately 1 month, Pfenex Inc has returned 23.08% as of today's recent price of $12.64.
Pfenex Inc. (NYSE American: PFNX) today announced that Serum Institute of India Private Limited (Serum Institute) achieved World Health Organization (WHO) prequalification for Pneumosil, a 10-valent pneumococcal...
Pfenex Inc (AMEX:PFNX) traded in a range yesterday that spanned from a low of $11.04 to a high of $11.34. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $11.23 on...
Pfenex Inc (AMEX:PFNX) traded in a range yesterday that spanned from a low of $11.45 to a high of $12.00. Yesterday, the shares fell 3.8%, which took the trading range below the 3-day low of $12.25 on...
Pfenex Inc. (NYSE American: PFNX) today announced that it has earned a $15 million development milestone under its development and license agreement with Jazz Pharmaceuticals plc. The milestone is associated...
SmarTrend identified an Uptrend for Pfenex Inc (AMEX:PFNX) on December 2nd, 2019 at $10.27. In approximately 2 weeks, Pfenex Inc has returned 19.08% as of today's recent price of $12.23.
Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....
We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...
Pfenex Inc (AMEX:PFNX) traded in a range yesterday that spanned from a low of $11.11 to a high of $11.76. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $11.01...
Pfenex Inc. (NYSE American: PFNX) is a development and licensing biotechnology company focused on leveraging its PfÄ"nex Expression Technology(R) to develop and improve protein therapies for unmet patient...
Pfenex Inc. (NYSE American: PFNX) is a development and licensing biotechnology company focused on leveraging its PfÄ"nex Expression Technology(R) to develop and improve protein therapies for unmet patient...
Pfenex Inc. (NYSE American: PFNX), today announced that Susan Knudson has resigned for personal reasons from her role as Senior Vice President, Chief Financial Officer effective November 13, 2019, but...
Pfenex (PFNX) delivered earnings and revenue surprises of 0.00% and 3.03%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Pfenex Inc. (NYSE American: PFNX) today announced that Eef Schimmelpennink, President and Chief Executive Officer, will be presenting at the Jefferies 2019 London Healthcare Conference on Wednesday, November...
Pfenex (PFNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pfenex Inc. (NYSE American: PFNX), a development and licensing biotechnology company focused on leveraging its PfÄ"nex Expression Technology(R) to develop and improve protein therapies for unmet patient...
Investors need to pay close attention to Pfenex (PFNX) stock based on the movements in the options market lately.
We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...
Pfenex Inc (AMEX:PFNX) traded in a range yesterday that spanned from a low of $8.47 to a high of $9.03. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $8.86 on...
Medical device manufacturing remains a strong market, driven by technological developments, an aging population, and increases in chronic and lifestyle diseases - trends that expand healthcare spending....
